An Iranian pharmaceutical company says it has has started clinical studies on a vaccine exclusively for the Omicron variant of Covid.
The vaccine has been dubbed Barakat-Plus.
Hassan Jalili the CEO of Iran’s Shafa PharMed factory said on Monday morning, Iran’s Health Ministry, after reviewing the scientific documentation, issued a code of conduct for the clinical study of the Barakat Plus vaccine.
In this study, all persons over 18 years of age who have previously received two doses of Cov-Iran Barakat or Sinopharm vaccine can be candidates for the Omicron jab.
“At this stage, the vaccine will be administered to 210 volunteers, and the preliminary results will be presented to the Food and Drug Organization two weeks after receiving the booster shot,” he said.
Regarding the latest statistics on the production of the first Iranian Covid vaccine, the CEO of Shafa PharMed factory said so far, about 60 million doses of CovIran Barakat vaccine have been produced in by the company.
The Palestinian Civil Defense service on Tuesday reported more than 10,000 people are still missing…
Iran’s Ham-Mihan newspaper says the country has experienced its highest inflation in 80 years during…
Officials from Rival Palestinian groups Fatah and Hamas have held a meeting in China for…
Dozens of faith, civil rights and progressive groups in the United States have expressed solidarity…
American lawmakers are in the process of drafting a bill aimed at responding to the…
The Palestinian death toll from Israel's military onslaught against the besieged Gaza Strip has jumped…